GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » Market Cap

BioCorRx (BioCorRx) Market Cap : $6.61 Mil (As of Apr. 27, 2024)


View and export this data going back to 2009. Start your Free Trial

What is BioCorRx Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BioCorRx's share price for the quarter that ended in Dec. 2023 was $0.78. BioCorRx's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 8.67 Mil. Therefore, BioCorRx's market cap for the quarter that ended in Dec. 2023 was $6.77 Mil.

BioCorRx's quarterly market cap increased from Jun. 2023 ($14.57 Mil) to Sep. 2023 ($15.04 Mil) but then declined from Sep. 2023 ($15.04 Mil) to Dec. 2023 ($6.77 Mil).

BioCorRx's annual market cap declined from Dec. 2021 ($29.01 Mil) to Dec. 2022 ($7.53 Mil) and declined from Dec. 2022 ($7.53 Mil) to Dec. 2023 ($6.77 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioCorRx's Enterprise Value for Today is $9.00 Mil.


BioCorRx Market Cap Historical Data

The historical data trend for BioCorRx's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx Market Cap Chart

BioCorRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.65 5.19 29.01 7.53 6.77

BioCorRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.53 14.34 14.57 15.04 6.77

Competitive Comparison of BioCorRx's Market Cap

For the Medical Care Facilities subindustry, BioCorRx's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCorRx's Market Cap Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioCorRx's Market Cap distribution charts can be found below:

* The bar in red indicates where BioCorRx's Market Cap falls into.



BioCorRx Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

BioCorRx's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$0.78*8.67403
=$6.77

BioCorRx's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$0.78*8.67403
=$6.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioCorRx  (OTCPK:BICX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


BioCorRx Market Cap Related Terms

Thank you for viewing the detailed overview of BioCorRx's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


BioCorRx (BioCorRx) Business Description

Traded in Other Exchanges
N/A
Address
2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806
BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication-assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.
Executives
Louis C. Lucido director 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan director, 10 percent owner 333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy director 5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola director 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch officer: Vice President of Operations 10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry director, officer: Chief Executive Officer 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier director 13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix director, officer: Chief Financial Officer 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade director, officer: Chief Executive Officer PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr director, officer: President 13231 SANDHURST PLACE, SANTA ANA CA 92705

BioCorRx (BioCorRx) Headlines

From GuruFocus

BioCorRx Featured on LiveNOW from FOX

By GuruFocusNews GuruFocusNews 06-17-2022

BioCorRx Provides Business Update for the Third Quarter of 2022

By Value_Insider Value_Insider 11-15-2022

BioCorRx Provides Business Update for the First Quarter of 2023

By sperokesalga sperokesalga 05-16-2023

BioCorRx Business Update for the First Quarter of 2022

By GuruFocusNews GuruFocusNews 06-16-2022

BioCorRx Appoints Pharmaceutical & Finance Veteran Harsha Murthy to the Board of Directors

By Stock market mentor Stock market mentor 01-24-2023

BioCorRx to Present at the LD Micro Invitational XII on June 7th

By GuruFocusNews GuruFocusNews 06-10-2022

BioCorRx Business Update for the First Quarter of 2022

By GuruFocusNews GuruFocusNews 06-26-2022